<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02536053</url>
  </required_header>
  <id_info>
    <org_study_id>324/13/03/02/2014/2</org_study_id>
    <nct_id>NCT02536053</nct_id>
  </id_info>
  <brief_title>Outcomes in Lower Extremity Soft Tissue Sarcoma Patients After Limb Salvage</brief_title>
  <official_title>Functional Outcomes and Health Related Quality of Life in Lower Extremity Soft Tissue Sarcoma Patients After Limb Salvage: A Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to:&#xD;
&#xD;
        1. validate the Finnish version of the Musculoskeletal Tumor Society scale and the Toronto&#xD;
           Extremity Salvage Score lower extremity sections and to&#xD;
&#xD;
        2. assess the functional ability and health-related quality of life (HRQoL) of lower&#xD;
           extremity sarcoma patients who have undergone limb salvage surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The first purpose of this study is to validate the Finnish version of the Musculoskeletal&#xD;
      Tumor Society scale and the Toronto Extremity Salvage Score upper extremity sections. The&#xD;
      second purpose is to chart the functional capabilities and health-related quality of life&#xD;
      (HRQoL) of upper extremity sarcoma patients who have undergone limb salvage surgery with&#xD;
      local or free flaps.&#xD;
&#xD;
      Patient hospital records are retrospectively reviewed to chart the demographic and clinical&#xD;
      data.&#xD;
&#xD;
      The recruitment of patient takes place at the outpatient clinic of Department of Oncology,&#xD;
      Helsinki University Hospital. The study includes a cross-sectional assessment at one year&#xD;
      follow-up with five validated questionnaires. A follow-up is conducted three years after&#xD;
      surgery in the outpatient clinic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">January 15, 2020</completion_date>
  <primary_completion_date type="Actual">January 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validity of the lower-limb Musculoskeletal Tumor Society score and the Toronto Extremity Salvage Score</measure>
    <time_frame>two to five years</time_frame>
    <description>The validity is studied</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reliability of the lower-limb Musculoskeletal Tumor Society score and the Toronto Extremity Salvage Score</measure>
    <time_frame>two to five years</time_frame>
    <description>The test-retest reliability is studied</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health-related quality of life after limb salvage</measure>
    <time_frame>two to five years</time_frame>
    <description>Assessment of health-related quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the functional ability after limb salvage</measure>
    <time_frame>two to five years</time_frame>
    <description>Assessment of functional ability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Questionnaire-Core 30</measure>
    <time_frame>two to five years</time_frame>
    <description>Health-related quality of life assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The 15-dimensions health-related quality of life instrument</measure>
    <time_frame>two to five years</time_frame>
    <description>Health-related quality of life assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Musculoskeletal Tumor Society score lower extremity section</measure>
    <time_frame>two to five years</time_frame>
    <description>Functional assessment of the reconstructed limb</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Toronto Extremity Salvage Score lower extremity section</measure>
    <time_frame>two to five years</time_frame>
    <description>Functional assessment of the reconstructed limb</description>
  </secondary_outcome>
  <enrollment type="Actual">141</enrollment>
  <condition>Limb Salvage</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Limb salvage</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Lower extremity sarcoma patient who underwent limb-salvage surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Lower extremity soft tissue sarcoma locating in between hip/gluteus to foot&#xD;
&#xD;
          -  No metastasis at the time of diagnosis&#xD;
&#xD;
          -  Undergone limb salvage surgery&#xD;
&#xD;
          -  A minimum of 1 year follow-up&#xD;
&#xD;
          -  Written consent&#xD;
&#xD;
          -  Age &gt; 18&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18&#xD;
&#xD;
          -  No limb-salvage surgery due to sarcoma&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erkki J Tukiainen, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University Hospital and University of Helsinki</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carl Blomqvist, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University Hospital and University of Helsinki</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cancer center, Helsinki University Hospital and University of Helsinki</name>
      <address>
        <city>Helsinki</city>
        <state>Helsinki And Uusimaa</state>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 18, 2015</study_first_submitted>
  <study_first_submitted_qc>August 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2015</study_first_posted>
  <last_update_submitted>January 15, 2021</last_update_submitted>
  <last_update_submitted_qc>January 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Jussi Repo</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>[E04.100.814.603]</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

